Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33090
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-06-21T06:29:38Z-
dc.date.available2023-06-21T06:29:38Z-
dc.date.issued2013-01-17-
dc.identifier.citationSezgin, M. E. vd. (2014). "Childhood immune thrombocytopenia: Long-term follow-up data evaluated by the criteria of the international working group on immune thrombocytopenic purpura". Turkish Journal of Hematology, 31(1), 32-39.tr_TR
dc.identifier.issn1300-7777-
dc.identifier.issn1308-5263-
dc.identifier.urihttps://doi.org/10.4274/Tjh.2012.0049-
dc.identifier.urihttps://jag.journalagent.com/tjh/pdfs/TJH_31_1_32_39.pdf-
dc.identifier.urihttp://hdl.handle.net/11452/33090-
dc.description.abstractObjective: Immune thrombocytopenia (ITP) is a common bleeding disorder in childhood, characterized by isolated thrombocytopenia. The International Working Group (IWG) on ITP recently published a consensus report about the standardization of terminology, definitions, and outcome criteria in ITP to overcome the difficulties in these areas. Materials and Methods: The records of patients were retrospectively collected from January 2000 to December 2009 to evaluate the data of children with ITP by using the new definitions of the IWG. Results: The data of 201 children were included in the study. The median follow-up period was 22 months (range: 12-131 months). The median age and platelet count at presentation were 69 months (range: 7-208 months) and 19x10(9)/L (range: 1x10(9)/L to 93x10(9)/L), respectively. We found 2 risk factors for chronic course of ITP: female sex (OR=2.55, CI=1.31-4.95) and age being more than 10 years (OR=3.0, CI=1.5-5.98). Life-threatening bleeding occurred in 5% (n=9) of the patients. Splenectomy was required in 7 (3%) cases. When we excluded 2 splenectomized cases, complete remission at 1 year was achieved in 70% (n=139/199). The disease was resolved in 9 more children between 12 and 90 months. Conclusion: Female sex and age above 10 years old significantly influenced chronicity. Therefore, long-term follow-up is necessary in these children.en_US
dc.description.abstractGereç ve Yöntemler: ITP’li hastalarımıza ait kayıtlar Ocak 2000’den Kasım 2009’a kadar, geriye yönelik olarak, IWG’nin yeni kriterleri kullanılarak değerlendirilmek üzere toplandı. Bulgular: İki yüz bir çocuğun verileri çalışmaya dahil edildi. Ortanca takip süresi 22 ay (12-131 ay) idi. Başvuru anında ortanca yaş ve trombosit sayısı, sırası ile 69 ay (7-208 ay) ve 19x109/L (1-93x109/L) idi. Hastalığın kronikleşmesi açısından iki risk faktörü saptadık: Kız cinsiyet (OR=2,55, CI=1,31-4,95) ve yaşın 10’dan büyük olması (OR=3,0, CI=1,5-5,98). Hayatı tehdit edici kanama, hastaların 5%’inde (n=9) görüldü. Splenektomi yapılması,7 hastada (3%) gerekti. İlk bir yılda splenektomi yapılan 2 hasta göz ardı edildiğinde, tam remisyon (CR) 70% (n=139/199) hastada görüldü. Hastalık, kronik ITP’li olguların 9’unda (%15; 9/60) daha tanıdan itibaren12 ile 90 ay içerisinde düzeldi. Sonuç: Kız cinsiyet ve yaşın 10’dan büyük olması, kronikleşmeyi belirgin olarak etkiledi. Ancak bu çocuklarda uzun sureli takip gereklidirtr_TR
dc.language.isoenen_US
dc.publisherGalenos Yayıncılıktr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectChildrenen_US
dc.subjectThrombocytopeniaen_US
dc.subjectLong-term survivalen_US
dc.subjectNatural-historyen_US
dc.subjectClinical characteristicsen_US
dc.subjectManagementen_US
dc.subjectChildrenen_US
dc.subjectSplenectomyen_US
dc.subjectItpen_US
dc.subjectDiagnosisen_US
dc.subjectHematologyen_US
dc.subjectTrombositopenitr_TR
dc.subjectÇocuktr_TR
dc.subjectUzun dönem takiptr_TR
dc.titleChildhood immune thrombocytopenia: Long-term follow-up data evaluated by the criteria of the international working group on immune thrombocytopenic purpuratr_TR
dc.title.alternativeÇocukluk Çağında İmmun Trombositopeni: Uluslararası İmmun Trombositopeni Çalışma Grubunun Kriterlerine Göre Uzun İzlem Verilerinin Değerlendirilmesitr_TR
dc.typeArticleen_US
dc.identifier.wos000347435400005tr_TR
dc.identifier.scopus2-s2.0-84905918527tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatrik Hematoloji Anabilim Dalı.tr_TR
dc.identifier.startpage32tr_TR
dc.identifier.endpage39tr_TR
dc.identifier.volume31tr_TR
dc.identifier.issue1tr_TR
dc.relation.journalTurkish Journal of Hematologyen_US
dc.contributor.buuauthorSezgin, Melike Evim-
dc.contributor.buuauthorBaytan, Birol-
dc.contributor.buuauthorGüneş, Adalet Meral-
dc.contributor.researcheridAAH-1452-2021tr_TR
dc.indexed.trdizinTrDizintr_TR
dc.identifier.pubmed24764727tr_TR
dc.subject.wosHematologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid36667380300tr_TR
dc.contributor.scopusid6506622162tr_TR
dc.contributor.scopusid24072843300tr_TR
dc.subject.scopusIdiopathic Thrombocytopenic Purpura; Romiplostim; Thrombocytopeniaen_US
dc.subject.emtreeAdolescenten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeChildhood diseaseen_US
dc.subject.emtreeChildhood immune thrombocytopeniaen_US
dc.subject.emtreeChronicityen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCoombs testen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHepatitis b rapid testen_US
dc.subject.emtreeHepatitis c rapid testen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeIdiopathic thrombocytopenic purpuraen_US
dc.subject.emtreeInfanten_US
dc.subject.emtreeLong term survivalen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMedical record reviewen_US
dc.subject.emtreeMucosal bleedingen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeSplenectomyen_US
dc.subject.emtreeThrombocyte counten_US
dc.subject.emtreeThrombocytopeniaen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeImmunoglobulin gen_US
dc.subject.emtreePrednisoneen_US
Appears in Collections:Scopus
TrDizin
Web of Science

Files in This Item:
File Description SizeFormat 
Evim_vd_2014.pdf157.39 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons